chr22-50570914-C-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_152246.3(CPT1B):āc.2005G>Cā(p.Val669Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000279 in 1,613,630 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_152246.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CPT1B | NM_152246.3 | c.2005G>C | p.Val669Leu | missense_variant | 16/20 | ENST00000312108.12 | NP_689452.1 | |
CHKB-CPT1B | NR_027928.2 | n.3570G>C | non_coding_transcript_exon_variant | 26/30 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CPT1B | ENST00000312108.12 | c.2005G>C | p.Val669Leu | missense_variant | 16/20 | 1 | NM_152246.3 | ENSP00000312189 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000164 AC: 25AN: 152246Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000281 AC: 7AN: 249194Hom.: 0 AF XY: 0.00000741 AC XY: 1AN XY: 134952
GnomAD4 exome AF: 0.0000137 AC: 20AN: 1461384Hom.: 0 Cov.: 32 AF XY: 0.0000124 AC XY: 9AN XY: 726992
GnomAD4 genome AF: 0.000164 AC: 25AN: 152246Hom.: 0 Cov.: 33 AF XY: 0.000148 AC XY: 11AN XY: 74390
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 17, 2022 | The c.2005G>C (p.V669L) alteration is located in exon 16 (coding exon 15) of the CPT1B gene. This alteration results from a G to C substitution at nucleotide position 2005, causing the valine (V) at amino acid position 669 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at